Cargando…
Astragalus polysaccharides (PG2) Enhances the M1 Polarization of Macrophages, Functional Maturation of Dendritic Cells, and T Cell-Mediated Anticancer Immune Responses in Patients with Lung Cancer
Background: Recently, we demonstrated that Astragalus polysaccharide (PG2), the active ingredient in dried roots of astragalus membranaceus, ameliorates cancer symptom clusters and improves quality of life (QoL) in patients with metastatic disease by modulating inflammatory cascade against the backg...
Autores principales: | Bamodu, Oluwaseun Adebayo, Kuo, Kuang-Tai, Wang, Chun-Hua, Huang, Wen-Chien, Wu, Alexander T.H., Tsai, Jo-Ting, Lee, Kang-Yun, Yeh, Chi-Tai, Wang, Liang-Shun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6836209/ https://www.ncbi.nlm.nih.gov/pubmed/31547048 http://dx.doi.org/10.3390/nu11102264 |
Ejemplares similares
-
Astragalus polysaccharide (PG2) Ameliorates Cancer Symptom Clusters, as well as Improves Quality of Life in Patients with Metastatic Disease, through Modulation of the Inflammatory Cascade
por: Huang, Wen-Chien, et al.
Publicado: (2019) -
Modulatory Effects of Astragalus Polysaccharides on T-Cell Polarization in Mice with Polymicrobial Sepsis
por: Hou, Yu-Chen, et al.
Publicado: (2015) -
Histone demethylase JARID1B/KDM5B promotes aggressiveness of non-small cell lung cancer and serves as a good prognostic predictor
por: Kuo, Kuang-Tai, et al.
Publicado: (2018) -
Anticancer activity of Astragalus polysaccharide in human non-small cell lung cancer cells
por: Wu, Chao-Yan, et al.
Publicado: (2017) -
Targeted PARP Inhibition Combined with FGFR1 Blockade is Synthetically Lethal to Malignant Cells in Patients with Pancreatic Cancer
por: Lai, Shiue-Wei, et al.
Publicado: (2020)